Keyphrases
Area Index
11%
Arthritis Patients
22%
Atherosclerotic Risk Factors
100%
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
11%
Blocking Agent
11%
Body Mass Index
33%
C-reactive Protein
22%
Carotid Duplex
11%
Clinical Pattern
11%
Common Carotid Artery
22%
Degree of Involvement
11%
Degree of Severity
22%
Disease Activity
11%
Duplex Scan
11%
Erythrocyte Sedimentation Rate
33%
Fatigue Degree
11%
Fibrinogen
33%
Healthy Controls
11%
Hypertension
33%
Intima-media
88%
Joint Degree
11%
Joint Disease
11%
Lipids
11%
Mean Standard Deviation
11%
Methotrexate
11%
Morning Stiffness
11%
Non-associated
11%
Non-modifiable Risk Factors
22%
Oligo
11%
Oligoarthritis
11%
Pain Level
11%
Polyarthritis
11%
Prevalence Factors
100%
Psoriasis Area
11%
Psoriasis Severity
11%
Psoriatic Arthritis
100%
Severity Index
11%
Skin Diseases
11%
Spinal Involvement
22%
Subclinical Atherosclerosis
11%
Swollen Joint
11%
Tender Joint
11%
Tumor Necrosis Factor-α
11%
Vascular Risk Factors
11%
Wall Thickness
88%
Medicine and Dentistry
Artery Intima
11%
Arthritis
11%
Arthropathy
11%
Atherosclerosis
100%
BASDAI
11%
Blocking Agent
11%
Body Mass Index
33%
C Reactive Protein
22%
Common Carotid Artery
22%
Dermatosis
11%
Disease Activity
11%
Erythrocyte Sedimentation Rate
33%
Fibrinogen
33%
Hyperlipidemia
22%
Methotrexate
11%
Morning Stiffness
11%
Polyarthritis
11%
Prevalence
100%
Psoriasis Area and Severity Index
11%
Psoriatic Arthritis
100%
Tumor Necrosis Factor
11%
Immunology and Microbiology
Ankylosing Spondylitis
11%
Artery Intima
11%
Arthritis
11%
Arthropathy
11%
Atherosclerosis
100%
Body Mass
33%
C-Reactive Protein
22%
Common Carotid Artery
22%
Erythrocyte Sedimentation Rate
33%
Fibrinogen
33%
Methotrexate
11%
Normal Human
11%
Oligoarthritis
11%
Polyarthritis
11%
Prevalence
100%
Psoriatic Arthritis
100%
Rigidity
11%
Spine
11%
Tumor Necrosis Factor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Ankylosing Spondylitis
11%
Arthritis
11%
Arthropathy
11%
Atherosclerosis
100%
Blocking Agent
11%
C Reactive Protein
22%
Disease Activity
22%
Fibrinogen
33%
Hyperlipidemia
22%
Methotrexate
11%
Morning Stiffness
11%
Normal Human
11%
Polyarthritis
11%
Prevalence
100%
Psoriasis
11%
Psoriatic Arthritis
100%
Skin Disease
11%
Tumor Necrosis Factor
11%